Persistent Racial Inequities in Acute Kidney Injury Among U.S. Hospitalizations: A Nationwide Cohort Analysis

This nationwide cohort analysis of 2022 U.S. hospitalizations reveals that significant racial and ethnic disparities in acute kidney injury incidence, dialysis utilization, and mortality persist even after adjusting for clinical and socioeconomic factors, underscoring the critical role of structural inequities in kidney health outcomes.

The Gist

Imagine the human body as a complex city, and the kidneys are the water treatment plants that keep the city clean by filtering out waste. When these plants suddenly break down, it's called Acute Kidney Injury (AKI). This is a medical emergency that happens to many people while they are in the hospital, often leading to longer stays, higher bills, and sometimes, tragedy.

This study is like a massive, nationwide weather report for kidney health. The researchers looked at millions of hospital records from 2022 to see if the "storm" of kidney failure hits some neighborhoods harder than others, and if the "emergency response" (treatment) is the same for everyone.

Here is the breakdown of their findings, using simple analogies:

1. The Uneven Storm (Who gets sick?)

The researchers found that the storm of kidney failure doesn't hit everyone equally.

• The Black Community: Imagine a neighborhood where the storm clouds are always darker and heavier. Black patients were significantly more likely to develop kidney failure while in the hospital compared to White patients, even after accounting for other health issues like diabetes or high blood pressure.
• Native American & "Other" Groups: These groups also faced a higher risk of the storm hitting them, though the risk was slightly lower than for Black patients.
• Asian/Pacific Islander & Hispanic Groups: Interestingly, these groups were slightly less likely to get kidney failure than White patients, or about the same.

The Takeaway: It's not just about bad luck or genetics. The study suggests that structural racism acts like a faulty drainage system in certain neighborhoods. Factors like where people live, their access to good food, and the quality of local hospitals make the "storm" more likely to strike certain communities.

2. The Survival Paradox (Who survives the storm?)

This is the most confusing part of the story, like a plot twist in a movie.

• The "Survivor" Effect: When Black and Hispanic patients did get kidney failure, they were actually slightly less likely to die in the hospital than White patients.
• The "High-Risk" Groups: Conversely, Asian/Pacific Islander and Native American patients who got kidney failure had higher odds of dying in the hospital.

Why is this happening? Think of it like a marathon. The study suggests that Black and Hispanic patients who make it to the hospital might be the "survivors" who have already beaten the odds of chronic illness to get there. They might be younger and tougher on average when they arrive. Meanwhile, the other groups might be older or sicker by the time they get help. It's a complex mix of age, timing, and who is able to get to the hospital in the first place.

3. The Emergency Response (Who gets the dialysis?)

Dialysis is like a temporary backup generator for the water treatment plant when it breaks down.

• The Disparity: Here is where the inequality is starkest. Every single non-White group was more likely to need this backup generator (dialysis) than White patients.
• The Analogy: Imagine two cars breaking down on the highway. The White driver gets a tow truck immediately. The Black, Hispanic, and Native American drivers are more likely to need a much more intensive, expensive, and invasive rescue operation (dialysis) to get moving again. This suggests that minority patients might be arriving at the hospital with more severe kidney damage, or that the "backup generator" is being used differently across groups.

4. The Money Factor (Does income fix it?)

You might think, "If people just had more money, the storm would pass."

• The Reality: The researchers checked this. They looked at rich vs. poor neighborhoods. While being poor does make things harder, money alone didn't fix the racial gap.
• The Metaphor: Even if you give a person in a disadvantaged neighborhood a brand-new car (money), they still have to drive on roads full of potholes and traffic jams (structural racism, segregation, lack of specialists). The "potholes" of systemic inequality are so deep that having a little extra cash doesn't stop the car from breaking down.

The Big Picture Conclusion

This study is a loud alarm bell. It tells us that kidney failure isn't just a medical problem; it's a social problem.

• The Problem: The system is rigged. Certain racial groups are more likely to get sick, more likely to need extreme treatments, and face different survival odds, not because of their biology, but because of how society is built.
• The Solution: We can't just treat the kidneys; we have to fix the "drainage system" of society. This means:
  • Building better "roads" (access to care) in minority neighborhoods.
  • Making sure every hospital has a "specialist mechanic" (nephrologist) ready to help.
  • Fixing the "weather" upstream by addressing poverty, pollution, and housing.

In short: The kidneys aren't failing because of who the people are; they are failing because of where they live and how the system treats them. To fix the kidneys, we have to fix the city.

Technical Summary

1. Problem Statement

Acute Kidney Injury (AKI) is a significant cause of morbidity, mortality, and healthcare resource utilization in the United States. While racial and ethnic disparities in Chronic Kidney Disease (CKD) and End-Stage Kidney Disease (ESKD) are well-documented, contemporary national data regarding racial inequities specifically in AKI remains limited. Existing studies often rely on older datasets, focus on narrow outcomes, or fail to fully account for socioeconomic gradients and hospital-level factors. Furthermore, it is unclear whether these disparities persist across the entire adult lifespan or vary by age. The study aims to characterize the magnitude of racial disparities in AKI incidence, in-hospital mortality, dialysis use, and resource utilization, adjusting for demographics, comorbidities, and socioeconomic status.

2. Methodology

• Study Design: Retrospective, cross-sectional analysis.
• Data Source: The 2022 National Inpatient Sample (NIS), the largest all-payer inpatient database in the U.S., representing approximately 35 million annual hospitalizations.
• Study Population: Hospitalized adults aged ≥18 years.
  • Exclusions: Hospitalizations with missing race data (3.2%) and pregnancy-related admissions.
  • Inclusion: All discharge dispositions were retained; elective vs. non-elective status was not an exclusion criterion.
• Definitions:
  • AKI: Identified via ICD-10-CM codes N17.x across all diagnosis fields.
  • Race/Ethnicity: Categorized per HCUP standards: Asian/Pacific Islander (API), Black, Hispanic, Native American, Other (non-White, non-Black, non-Hispanic, non-API, non-Native American), and White (reference group).
  • Socioeconomic Status: Measured by ZIP code–level median household income quartiles.
• Variables:
  • Covariates: Age, sex, primary payer, and comorbidities (CKD, heart failure, diabetes, hypertension, obesity, COPD, liver disease, sepsis).
  • Outcomes:
    • Primary: In-hospital mortality and dialysis use (among AKI patients).
    • Secondary: Mechanical ventilation, shock, cardiac arrest, length of stay (LOS), total hospital charges, and discharge disposition.
• Statistical Analysis:
  • Descriptive: Survey-weighted means and percentages with standardized mean differences.
  • Regression Models: Three survey-weighted logistic regression models were constructed:
    1. Odds of developing AKI (vs. non-AKI).
    2. Odds of in-hospital mortality (among AKI patients).
    3. Odds of dialysis use (among AKI patients).
  • Adjustments: All models adjusted for age, sex, payer, and the full list of comorbidities.
  • Age-Specific Modeling: Predicted probabilities of AKI were derived to visualize risk differences across the adult lifespan.
  • Software: R 4.3 (packages: survey, srvyr, tidyverse, broom, ggeffects).

3. Key Contributions

• Contemporary National Profile: Provides the most recent (2022) nationwide assessment of racial disparities in AKI, addressing gaps in older literature.
• Multidimensional Analysis: Simultaneously evaluates incidence, mortality, dialysis utilization, and resource use, offering a holistic view of the "AKI burden."
• Age-Stratified Risk: Moves beyond aggregate statistics to model how racial disparities in AKI risk evolve across the entire adult lifespan (ages 18+).
• Decoupling Income and Race: Explicitly tests whether income quartiles explain racial disparities, finding that they do not, thereby highlighting the role of structural racism beyond mere socioeconomic status.

4. Key Results

A. Baseline Characteristics

• Demographics: White patients were older (mean age 62.1) compared to Black (53.6) and Hispanic (49.9) patients.
• Comorbidities: Black patients had the highest prevalence of CKD (25.1%) compared to White patients (18.7%).
• Unadjusted AKI Prevalence: Ranged from 15.3% (Hispanic) to 22.8% (Black).

B. Adjusted Associations (Odds Ratios)

After adjusting for demographics, payer, and comorbidities:

• AKI Incidence:
  • Higher Risk: Black (OR 1.34), Native American (OR 1.08), and Other (OR 1.07).
  • Lower/Similar Risk: API (OR 0.94) and Hispanic (OR 0.98).
• In-Hospital Mortality (among AKI patients):
  • Higher Risk: API (OR 1.16), Native American (OR 1.19), and Other (OR 1.17).
  • Lower Risk: Black (OR 0.94) and Hispanic (OR 0.96).
  • Note: This "mortality paradox" (lower mortality despite higher incidence) is consistent with prior literature suggesting survivor bias or differences in pre-hospital health trajectories.
• Dialysis Use (among AKI patients):
  • All non-White groups had significantly higher odds of requiring dialysis compared to White patients:
    • API (OR 1.49), Hispanic (OR 1.34), Native American (OR 1.36), Other (OR 1.30), Black (OR 1.18).

C. Age-Specific Risk

• Predicted probability curves showed that Black patients consistently had a higher risk of AKI than White patients across all adult ages, with absolute risk differences peaking at 3–4 percentage points between ages 40 and 60.
• Disparities were persistent across the lifespan, suggesting cumulative exposure to inequities rather than age-specific drivers.

D. Socioeconomic Context

• While lower income was associated with higher AKI prevalence and resource use, income quartiles did not eliminate racial disparities. Significant racial differences in mortality and dialysis use persisted even when stratified by income.

5. Significance and Implications

• Structural Drivers: The persistence of disparities after adjusting for clinical comorbidities and income suggests that structural racism (e.g., neighborhood disadvantage, unequal access to preventive care, hospital quality variation, and environmental exposures) is a primary driver of AKI inequities.
• Clinical & Policy Recommendations:
  • Targeted Interventions: Need for equitable access to early nephrology consultations, particularly in minority-serving hospitals.
  • Quality Audits: Hospitals should audit disparities in AKI recognition, fluid management, and dialysis initiation.
  • Upstream Determinants: Policy must address non-clinical factors, including environmental nephrotoxins, clean water access, and transportation support.
• Limitations: The study relies on administrative coding (ICD-10) rather than laboratory-based KDIGO criteria, which may under-identify mild AKI. Race is administratively recorded and may not capture sociocultural nuances. However, the authors note that these limitations likely bias estimates toward the null, meaning true disparities may be even larger.

Conclusion: The study confirms that racial inequities in AKI are deep-seated, spanning incidence, severity, and resource utilization, and are not merely a function of socioeconomic status or comorbidity burden. Addressing these gaps requires a coordinated clinical and public health strategy targeting upstream structural determinants.